(NASDAQ: NEOG) Neogen's forecast annual revenue growth rate of -0.45% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.46%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12%.
Neogen's revenue in 2026 is $883,991,000.On average, 7 Wall Street analysts forecast NEOG's revenue for 2027 to be $197,599,706,675, with the lowest NEOG revenue forecast at $189,266,965,357, and the highest NEOG revenue forecast at $203,827,977,825. On average, 7 Wall Street analysts forecast NEOG's revenue for 2028 to be $190,766,727,811, with the lowest NEOG revenue forecast at $176,928,308,316, and the highest NEOG revenue forecast at $214,025,052,673.
In 2029, NEOG is forecast to generate $206,997,781,439 in revenue, with the lowest revenue forecast at $185,143,164,375 and the highest revenue forecast at $226,383,357,258.